Globalpharma, a leading generics manufacturer in the UAE and a wholly owned subsidiary of Dubai Investments, has reduced its carbon footprint by approximately 11,400 tonnes of CO₂ through the installation of a 612 kWp (kilowatt-peak) rooftop solar photovoltaic (PV) system at its manufacturing facility in Dubai Investments Park (DIP).
Globalpharma, a wholly owned subsidiary of Dubai Investments and one of the UAE’s leading pharmaceutical manufacturers, has signed a strategic distribution agreement with United Medical Supplies (UNIMED), a key healthcare distributor under the Mohamed & Obaid Al Mulla Group.
